Pediatric Study Royalty Fund Would Be Created By Wellstone Amendment
This article was originally published in The Tan Sheet
Executive Summary
Drug companies would be required to set aside a portion of product sales to fund pediatric research for off-patent drugs under an amendment Sen. Paul Wellstone (D-Minn.) will offer to the pediatric exclusivity reauthorization bill when it is considered on the Senate floor.